Update on Asthma Management Guidelines
- PMID: 39421468
- PMCID: PMC11482852
Update on Asthma Management Guidelines
Abstract
The Global Initiative for Asthma (GINA) was established in 1993 and publishes a yearly global strategy to improve asthma awareness, prevention and management of asthma worldwide, based on a review of the most updated evidence. The current 2024 GINA update advises that all adults and adolescents with asthma receive inhaled corticosteroid (ICS)- containing medication and should not be treated with short acting beta agonist (SABA) alone. The 2024 GINA strategy divides treatment into two 'Tracks": Track 1 (preferred Track), the reliever is as-needed combination low dose ICS-formoterol; Track 2 uses SABA as the reliever along with a separate ICS inhaler. The updates also stress the importance that individuals with asthma should have a written asthma action plan, and asthma management should be tailored to the individual to help reduce the occurrence of serious exacerbations, fatalities, and hospitalizations.
Copyright 2024 by the Missouri State Medical Association.
Conflict of interest statement
Disclosure: No financial disclosures reported. Artificial intelligence was not used in the study, research, preparation, or writing of this manuscript.
Figures
References
-
- World Asthma Day. Global Initiative for Asthma - GINA. 2024. [Accessed April 28, 2024]. https://ginasthma.org/world-asthma-day-2024/#:~:text=Asthma%20is%20one%2... .
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical